BNP Paribas Exane Cuts Cooper Companies (NASDAQ:COO) Price Target to $92.00

Cooper Companies (NASDAQ:COO) had its target price cut by research analysts at BNP Paribas Exane from $95.00 to $92.00 in a research note issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the medical device company’s stock. BNP Paribas Exane’s price objective points to a potential upside of 36.09% from the company’s previous close.

Other equities research analysts have also recently issued reports about the stock. Barclays increased their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Citigroup reiterated a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Wells Fargo & Company reissued a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Finally, Rothschild & Co Redburn cut Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research note on Wednesday, March 4th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $82.64.

Cooper Companies Trading Up 0.4%

Cooper Companies stock traded up $0.26 during trading hours on Monday, hitting $67.60. The stock had a trading volume of 3,020,908 shares, compared to its average volume of 2,299,306. The business’s 50 day simple moving average is $65.09 and its 200-day simple moving average is $74.54. The stock has a market cap of $13.19 billion, a price-to-earnings ratio of 57.24, a P/E/G ratio of 1.73 and a beta of 0.87. Cooper Companies has a one year low of $58.89 and a one year high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts predict that Cooper Companies will post 4.63 EPS for the current fiscal year.

Institutional Investors Weigh In On Cooper Companies

Hedge funds have recently modified their holdings of the stock. Root Financial Partners LLC increased its stake in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares in the last quarter. SJS Investment Consulting Inc. lifted its stake in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after buying an additional 187 shares in the last quarter. Bell Investment Advisors Inc boosted its holdings in Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares during the period. CYBER HORNET ETFs LLC purchased a new position in Cooper Companies in the 2nd quarter valued at approximately $36,000. Finally, True Wealth Design LLC raised its holdings in Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after acquiring an additional 383 shares during the period. Institutional investors own 24.39% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.